John R. MacDonald

John has over 30 years of experience in all aspects of pharmaceutical drug development and licensing. He led the preclinical and clinical R&D efforts at MGI Pharma, an oncology-focused company, from 1996 through 2005, and served as a consultant through MGI’s acquisition by Eisai in 2008. Prior to MGI he worked in large pharma at Warner-Lambert (now Pfizer) and in academia as an NIH funded researcher at UC San Francisco. Since 2006 he has remained active in drug development as a consultant advising academic institutions, startup and small pharma companies as the founder of Ridge Road Consulting and as the acting CEO of PepTx, Inc., a University of Minnesota startup. Dr. MacDonald earned a PhD in Pharmacology and Toxicology from the University of Arizona.